BioSig Allowed First Key US Patent Claims for its PURE EP™ System

Santa Monica, CA, May 23, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the US Patent Office allowed 33 patent claims covering its PURE EP™ System. The patent application number 16/271,462 entitled "System and Methods to Visually Align Signals Using Delay," was filed on May 9, 2018…